Source briefingSeptember 3, 2026Human Rights
EU Partnership Talks with Bahrain Should Seek Activists’ Release

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
Click to expand Image Abdulhadi al-Khawaja (left) and Mohamed Habib al-Muqdad. © Bahrain Centre for human rights/Wikimedia and Private For over 15 years, Danish human rights defender Abdulhadi al-Khawaja and Swedish activist Mohamed Habib al-Muqdad have been languishing in Bahrain’s prisons, as their governments and the European Union (EU) have failed to secure their release from unjust detention.
As the EU launched negotiations for a “Strategic Partnership Agreement” with Bahrain in July, it should use them to ensure that al-Khawaja, al-Muqdad and…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: Human Rights Watch News · September 3, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

EMA/PE/0000181364
What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…

EMA/PE/0000228795
Evidence Dossier: EMA Paediatric Investigation Plan for Ambrisentan/Tadalafil What is established The European Medicines Agency (EMA) has officially adopted a paediatric investigation plan (PIP)…

EMA/PE/0000261344
Evidence Dossier: EMA Decision on Colchicine Paediatric Investigation Plan (PIP) What is established On 8 August 2025, the European Medicines Agency (EMA) granted a…